AhR antagonist completely abolished the ameliorating effects of XANA on colitis, including body weight, DAI, colon length, colon histology, and serum levels of IL‐1β, IL‐6, TNF‐α, IL‐4, IL‐10, and IL‐22 (Figure7A–O). This evidence concerns the gene IL6 and colitis.